Atorvastatin Calcium
Product Images NDC 70934-482

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70934-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 482 96 Master Bottle Label Approval Rev A 04 20)

This is a description of the medication Atorvastatin Calcium Tablets, which is available only with a prescription (Rx Only). The tablets come in a pack of 20 and have either 10mg or 20mg potency. The NDC (National Drug Code) for the medication is 70934-482.96, and the IR (Immediate Release) number is 5523 106. No other relevant information is available due to the text being partially unreadable.*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

This is a chart showing the cumulative incidence in percentages for Atorastatn and Placsbo over a period of 35 years. The chart shows that Atorastatn has a lower incidence rate compared to Placsbo with a hazard ratio of 0.64 and p-value of 0.0005.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

This is a graph illustrating the cumulative hazard percentage over the course of four years for a placebo and Atorvastatin. The Hazard Ratio (HR) for Atorvastatin is reported as 0.63 with a 95% confidence interval of (0.48-0.83) and a p-value of 0.001. The x-axis corresponds to the time to the first primary endpoint, while the y-axis measures the hazard percentage.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

This is a table that shows the percentage of subjects who experienced a major cardiovascular event after taking different doses of Atorvastatin at different time intervals. The table shows that Atorvastatin 80 mg had a lower rate of cardiovascular events compared to Atorvastatin 10 mg. The HR (Hazard Ratio) for Atorvastatin 80 mg was 0.78 which shows a lower risk of major cardiovascular events. The time to first major cardiovascular endpoint ranged from 1 year to 4 years.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.